
Albio is to join Stago, global IVD Coagulation leader
The Stago Group has recently acquired Albio with the aim of developing its direct sales in Turkey.
Read moreAlbio is to join Stago, global IVD Coagulation leader
The Stago Group has recently acquired Albio with the aim of developing its direct sales in Turkey.
Read morePaper instruction manuals and Stago’s Web 3.0 policy
The IFU (Instructions For Use) platform can be accessed from the website www.stago.com, where users will find the digital version of our documents.
Read moreAlbio is to join Stago, global IVD Haemostasis leader
The Stago Group, the world leader in Haemostasis and Thrombosis, has recently acquired Albio with the aim of developing its direct sales in Turkey.
Read moreSTA-Liatest D-Di receives full 510(k) clearance from US FDA for DVT & PE exclusion
On December 10th, 2016 the US Food and Drug Administration (FDA) cleared STA-Liatest D-Di for the exclusion of the diagnosis of Deep Vein Thrombosis (DVT) on data reported from the multi-national, DiET study. Exclusion of the diagnosis of Pulmonary embolism (PE) was previously 510(k) cleared in 2014.
Read moreResults of the DiET Study have been recently published in Blood coagulation fibrinolysis, July 2016.
Read more